# Famotidine

## Famotidine 20mg

| 藥物代碼 | OFAMO |
| :--- | :--- |
| 適應症 | Gastric ulcer, duodenal ulcer, anastomotic ulcer, upper gastrointestinal bleeding \(peptic ulcer, acute stress ulcer, hemorrhagic gastritis\), reflux esophagitis, Zollinger-Ellison syndrome |
| 副作用 | &gt;10%: Central nervous system: Agitation \(infants: ?14%; adults: &lt;1%\)1% to 10%:Central nervous system: Headache \(5%\), dizziness \(1%\)Gastrointestinal: Diarrhea \(2%\), constipation \(1%\), necrotizing enterocolitis \(very low birth weight neonates; Guillet 2006\)Frequency not defined: Local: &lt;1%, postmarketing, and/or case reports: Abdominal distress, acne vulgaris, agranulocytosis, alopecia, anaphylaxis, angioedema, anorexia, anxiety, arthralgia, asthenia, atrioventricular block, bronchospasm, cardiac arrhythmia, cholestatic jaundice, confusion, conjunctival injection, decreased libido, depression, drowsiness, facial edema, fatigue, fever, flushing, hallucination, hepatitis, hypersensitivity reaction, impotence, increased liver enzymes, insomnia, interstitial pneumonitis, leukopenia, muscle cramps, musculoskeletal pain, nausea, palpitations, pancytopenia, paresthesia, periorbital edema, prolonged Q-T interval on ECG, pruritus, psychiatric disturbance, rhabdomyolysis, seizure, skin rash, Stevens-Johnson syndrome, taste disorder, thrombocytopenia, tinnitus, toxic epidermal necrolysis, urticaria, vomiting, xeroderma, xerostomia |
| 禁忌 | Serious hypersensitivity \(eg, anaphylaxis\) to famotidine, other H2 antagonists, or any component of the formulation |
| 懷孕用藥危分級 | 尚未確立 |
| 孕期用藥建議 | Compatible |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | AC, AC15, PC, PO, WM |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

